Navigation Links
HSPH Dean Barry R. Bloom to receive honorary doctorate from Erasmus University Rotterdam

Boston, MA Barry R. Bloom, PhD, Dean of the Harvard School of Public Health (HSPH), will receive today an Honorary Doctorate from Erasmus University Rotterdam in the Netherlands.

The University annually awards one or more honorary doctorates to mark its founding, a celebration called Dies Natalis. Last years awardees were Professor Sir Clive W.J. Granger, who shared the 2003 Nobel Prize in Economics, and Professor Arnold Zellner, a leading American economist and statistician. For a list of previous recipients of honorary doctorates from the University, see

Dean Bloom, an internationally recognized expert in immunology and infectious diseases, is a leader in global health policy as a member of scientific advisory boards for the World Health Organization, the National Institutes of Health, the Centers for Disease Control and Prevention, independent foundations, and as a former consultant to the White House on international health policy. He continues to pursue an active interest in bench science as the principal investigator of a laboratory researching the immune response to tuberculosis, a disease that claims more than two million people each year. Dean Bloom is also Joan L. and Julius H. Jacobson Professor of Public Health.

In a letter to Dean Bloom, Professor Steven W.J. Lamberts, Rector Magnificus at Erasmus University Rotterdam, wrote that the Doctorate Board was conferring the honorary doctorate, in recognition of your outstanding studies on the immune response in tuberculosis, in particular of its genetic control, and on your work on various techniques in vaccine development. You are also honored for your towering contribution to international health and leadership in public health education. The position of Rector Magnificus is comparable to a university's Chancellor.

The ceremony will take place at Erasmus University Rotterdam today, November 8, 2007. Dean Bloom will speak on Agendas and Architecture of Global Health.

Dean Bloom holds a bachelor's degree in biology from Amherst College and a doctoral degree in immunology from Rockefeller University.

He is a past president of the American Association of Immunologists and the Federation of American Societies for Experimental Biology. He received the first Bristol-Myers Squibb Award for Distinguished Research in Infectious Diseases in 1991, shared the Novartis Award in Immunology in 1998, and was the recipient of the Robert Koch Gold Medal for lifetime research in infectious diseases in 1999.

Erasmus University Rotterdam grew out of the Netherlands School of Commerce founded in 1913. The University has been in existence in its present form since 1973 after the Medical Faculty Rotterdam and the Netherlands School of Economics merged. For more information about the university, see


Contact: Christina Roache
Harvard School of Public Health

Related medicine news :

1. 4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote Recovery Happens! Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento
2. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
3. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, & Countrys Top Drug Treatment CEO Barry Karlin to Keynote Palm Beach, FL National Moment Of Change Intervention Conference:
4. Bloomberg receives award for promotion of health in NYC and nation
5. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
6. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
7. DaVita Receives Civil Complaint
8. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
9. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
10. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
11. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... An ... directory is specialized and only includes chiropractic clinics in the US. , The ... trustworthy alternative health practitioner when back pain sets in. When people are experiencing ...
(Date:11/30/2015)... ... November 30, 2015 , ... In ... Halloween festivities, the Word of Life Christian Church of Flint, MI, hosted a ... a giant 1.25 ton pile of candy dubbed “Candy Mountain”. , A Forever ...
(Date:11/30/2015)... ... November 30, 2015 , ... During ... fundraising campaign to raise funds for its research, education, support, and advocacy efforts. ... organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also goes by ...
(Date:11/30/2015)... ... November 30, 2015 , ... The ... in Dallas, TX, on January 29 and 30, 2016. The course welcomes dental ... of their practices, to learn how to better succeed in the modern dental ...
(Date:11/30/2015)... ... November 30, 2015 , ... HemoTreat™ has announced that the ... ointment to its website. , “Our goal is simple:” says Michael Blasco, HemoTreat’s ... the comparison chart and ingredient list allows our customers to quickly see why, ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... Free Press as a Top Workplace , among the ... work for in 2015. ... annually, based on employee surveys rating company leadership, career opportunities, ... based solely on employee feedback. The survey is conducted by ...
(Date:11/30/2015)...  IBA Molecular North America, Inc. (IBAMNA), a U.S. ... that as of January 1, 2016, it will do ... to rebrand the company reflects a refined vision for ... close relationship with Zevacor Molecular.  Both IBAMNA and Zevacor ... Peter Burke , Vice President Sales ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology: